Skip to content

Effect of Regular Uric Acid Monitoring on Uric Acid Control in Patients With Hyperuricemia Receiving Urate-Lowering Therapy: A Randomized Controlled Clinical Trial

Effect of Regular Uric Acid Monitoring on Uric Acid Control in Patients With Hyperuricemia Receiving Urate-Lowering Therapy: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097492
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Interventions

Uric acid monitoring group:On a fixed day a week, patients used Jackjet uric acid meter + 60 test strips to measure blood uric acid on an empty stomach in the morning, 2 hours ± 15min and 11pm±30min a
Non-uric acid monitoring group:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male aged 18-65; 2. Patients diagnosed with hyperuricemia refer to the fasting test of blood uric acid > 420µmol/L (7mg/dl) twice on the same day under normal purine diet 3. As judged by the physician, it is currently necessary to use febuxostat 40mg once a day to start regular uric acid-lowering drug treatment.

Exclusion criteria

Exclusion criteria: 1. Use of drugs that may affect uric acid within 2 weeks before enrollment, including: benzbromarone, allopurinol, febuxostat, etc.; 2. Severe hepatic insufficiency or kidney disease (AST or ALT > 3 times the upper limit of normal, or eGFR <30ml/min/1.73m2); 3. If other drugs are used in combination, the drug dose should be kept stable for three months before enrollment; 4. Unable to cooperate with regular self-monitoring of uric acid.

Design outcomes

Primary

MeasureTime frame
Uric acid;

Secondary

MeasureTime frame
Patient medication adherence;How often doctors adjust their medication regimens;Frequency of gout attacks;Change in nail uric acid content at 12 weeks from baseline ;

Countries

China

Contacts

Public ContactHaibing Chen

Shanghai Tenth People's Hospital

hbchen@tongji.edu.cn+86 189 3017 3813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026